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Barriers to the growth of artificial intelligence within the NHS 
 
Introduction 
 
Artificial intelligence (AI), regarded as the ability of systems to replicate human behaviour in an intelligent manner, 
shows great promise within the NHS. Increased automation of repetitive clinical and administrative tasks has the 
potential to save the NHS up to £12.5 billion a year worth of staff time (1) which could be invaluable to the NHS in 
addressing increasing pressures to meet financial and performance targets. Although artificial intelligence has been 
around for many years, advancements in AI methods in recent decades has resulted in increasingly sophisticated 
programs with the ability to revolutionise industries such as healthcare. Specifically, breakthroughs in machine learning, 
one of the most widely used branches of AI has led to algorithms capable of equalising the diagnostic skills of doctors, 
automating administrative tasks and assisting in complex treatment management to name a few. Within the NHS, some 
examples of the successful applications of AI can be seen such as the collaboration between British AI company 
DeepMind’s and Moorfields eye hospital in accurately detecting and prioritising eye conditions (appendix A) (2) and 
Heart flow (3), an image analysis software using AI to construct detailed images of a patient’s heart (appendix B). From 
an administrative perspective, East Suffolk and North Essex NHS foundation trust is currently deploying a system using 
AI to directly tackle tasks such as the management of GP referrals and processing of blood and scan results. This system 
has already saved staff 570 hours of work in the space of three months and therefore shows the promise of automating 
repetitive admin tasks which currently demand substantial amounts of staff time (4). Although these, amongst others, 
are extremely promising examples of potential applications of AI within the NHS, it is important to note that the majority 
of these are trialled or used in practice within individual NHS boards rather than nationally. The UK government has 
stated that the NHS has the potential to become a world leader in AI (5) with advancements potentially transforming 
the prevention, early diagnosis and treatment of diseases. Despite this, the widespread use of artificial intelligence within 
the NHS evidently has not yet been achieved.  The various factors which have been identified in preventing the growth 
of artificial intelligence within the NHS will be discussed within this project.  
 
Technological advancements within AI 
 
Broadly speaking, artificial intelligence is a field within computer science which aims to develop computer programs 
that demonstrate features of human intelligence. This includes the capacity to learn, plan, reason and self-correct. 
Although several branches of AI are currently used in technology today, one branch that has proven to be particularly 
prominent over the past decade is machine learning (ML), a method of analysing data which allows software to learn 
without being explicitly programmed (appendix C). Programs initially learn from being exposed to large sets of data, 
identify features from this data and analyse this to make predictions about information it has not previously been exposed 
to.  This recent growth in machine learning is partly due to the rise of the internet with large datasets being more readily 
available than ever before in addition to the recognition of the increased efficiency of the self-teaching nature of new 
ML methods such as deep learning. Machine learning systems are notably efficient in tasks involving the analysis of 
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large datasets of images as well as the automation of repetitive processes and therefore could be particularly 
advantageous in healthcare.  
 
Despite its advantages, machine learning can pose multiple problems with regards to regulation, transparency and data 
usage. The most efficient and newest models of ML known as deep learning methods, are black box in nature meaning 
it is not always clear to the user or even the developer how exactly the program reaches a certain answer. This is 
acceptable in some industries, however, it can prove a considerable problem for regulation and accountability in safety 
critical industries. Additionally, the use of existing and ‘real time’ NHS data, which would be necessary to train 
algorithms specific for healthcare in the UK, raises ethical issues with regards to appropriate management, including 
collection, storage and distribution of the data. Despite these concerns, artificial intelligence and machine learning 
promise huge advantages within healthcare in terms of financial savings and improved clinical practice and so with 
careful navigation of some key barriers, it might be possible to develop appropriate models that sufficiently protect and 
support developers, NHS staff and the public in the increasing use of AI. 
 
 
Current barriers preventing the growth of artificial intelligence within the NHS 
 
The use of public data in training AI algorithms 
  
The NHS collects and records vast amounts of data on a daily basis providing a valuable opportunity in AI where, as 
previously mentioned, methods such as machine learning require training by large datasets. As stated by Lord James 
O’Shaughnessy, NHS data “is an asset that no other country can bring together” (6) and utilising this appropriately is 
key to the successful adoption of artificial intelligence within the NHS.  
 
Although the volume of data required for developing AI currently exists within the NHS, it is of equal importance that 
this data is of sufficient quality to ensure algorithms are accurately trained. According to a recent report carried out by 
NHS England and the AHSN network, however, respondents considered current NHS datasets patchy, dirty and often 
incorrect (7) and overall of an inadequate quality for use in AI training. Additionally, a research scientist at British AI 
company DeepMind stated that because of uncleaned, unrepresentative and disconnected NHS datasets it took several 
months to prepare relevant data before work could even begin on one of their diagnostic AI applications (8) proving to 
be a major inconvenience in the early stages of development. In addressing this, it would seem appropriate that it is 
necessary to establish a digital framework holding datasets appropriately prepared for AI use that can be easily accessed 
by approved developers. One of the first steps in achieving this, however, is the digitalisation of all NHS data which is 
a step that the NHS has struggled with across the board. Despite current targets claiming a paperless NHS will be 
achieved by 2020, this is now looking as overly ambitious as the previous target of 2018 with some experts predicting 
this cannot feasibly be achieved before 2027(9). Even after digitilisation, the requirement for data to be stored in an 
appropriate format ensuring data is machine readable, accurate and “clean” needs to be considered. The performance of 
ML algorithms is reliant on the information that is fed to them – if this information is incomplete, or contains 
inaccuracies, then this will be reflected in its output with potentially catastrophic consequences. Although the 
development of an appropriate digital infrastructure may be a challenge both in terms of labour and finances, the 
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significant time dedication for data organisation, which is currently required at the start of most AI developments, is 
currently proving to be a major impedance to developers and therefore is crucial to address. 
 
In addition to the practical requirements mentioned above, the use of large sets of sensitive public information, carries 
the potential for inappropriate use and must be subject to relevant ethical and legal considerations by both developers 
and NHS trusts. This is particularly relevant for AI which, in some applications, use large datasets that even when 
anonymised contain significant amount of unique identifiers that could be linked to data subjects. As stated in a recent 
report carried out by KPMG, 51% of the public are currently concerned about their data privacy as the use of AI increases 
and this is particularly relevant for those with minimal knowledge of current AI technology (10). Although appropriate 
legal (e.g. The Data Protection Act 2018) and ethical frameworks (e.g. The Data Ethics Framework) are in place 
designed to safeguard patients, the growth of machine learning and its absolute need for real life data could present an 
ethical dilemma where public data is being used as an exploitable resource utilised for purposes outwith what it was 
originally collected for. An example of this has already occurred where Royal Free NHS trust failed to obtain appropriate 
consent for the use of 1.6 million patient’s data in the development of one of its AI applications (11). Repeated episodes 
of this has the potential to decrease public trust in the NHS’s handing of public data and with the recent introduction of 
National data opt-out programme for patient information (12), it is easier than ever for patients to simply refuse to hand 
over their valuable information. It is therefore crucial to ensure that with the growing AI movement, work is committed 
to ensuring the public are sufficiently educated and engaged in consenting to the use of their personal data for use in AI.  
Additionally, it is necessary to guarantee that patient information continues to be viewed as a valued asset subject to 
appropriate ethical and legal considerations as opposed to a “free-for-all” for use in training AI algorithms.  
 
Regulation 
 
Regulation of AI software is a particularly complex area with advancements exceeding the pace at which regulatory 
guidance is adapting. As observed by Sherer (13), the rise of AI has so far occurred in a regulatory vacuum with minimal 
guidelines existing specifically addressing the unique challenges posed by AI. Regulation of medical devices, including 
medical software, in the UK is currently enforced by the medicines and healthcare products regulatory agency (MHRA) 
which requires developers to obtain a CE marking thereby demonstrating products have conformed to EU legislation. 
Additionally, products using public data for uses such as AI must abide to the necessary Data Protection laws. Up until 
recent years these regulatory frameworks, although ensuring the safety of products, have failed to address key regulatory 
challenges within AI such as the associated transparency issues. Over the past year, however, regulatory updates have 
been made attempting to address these insufficiencies both within Europe through the updated General data protection 
regulation (2018) and within the UK by the government through the publication of a code of conduct for AI and data 
driven technology. (14).  
 
The updated General data protection regulation (2018) is of particular interest to AI developers as its newly added 
clauses specifically address the use of public data within AI. Although these have been introduced to further safeguard 
patient privacy, it is arguable that some clauses have meant that new hurdles have been created for developers to 
overcome. For example, as part of the updated act developers must provide “meaningful information” about the logic 
involved within these tools. Although this attempts to address the transparency issue associated with black box coding 
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in AI and specifically ML, it can be difficult and sometimes impossible to demonstrate this logic. As stated by the Centre 
for Data Innovation, “Policymakers should understand that the GDPR will come at a significant cost in terms of 
innovation and productivity” and that failing to amend the GDPR will “consign Europe to second-tier status in the 
emerging AI economy” (15). 
 
The government recognises and accepts that introducing regulation that sufficiently protects patients without stifling 
innovation within AI is central to creating a market that can lead on global adoption of AI technologies (16) and is 
therefore currently reviewing existing health and care regulatory landscape (14). It would seem appropriate that, when 
establishing the scope of AI regulation in the future, input from those with knowledge in AI technology is included in 
discussions to establish an appropriate regulatory solution that both considers both the public and developers’ best 
interests.   
 
Accountability 
 
It is commonly accepted that nearly all AI software will fail to perform its intended purpose at some point during its 
lifetime. Although in some sectors AI failures can be trivial, in environments such as healthcare failures can have 
catastrophic consequences and in these situations it is vital to be able to hold the relevant party accountable. The 
assignment of accountability in AI and specifically machine learning, however, can be somewhat challenging primarily 
due to the lack of transparency used in many AI models. As stated by Dr Pavel Klimov (17), humans may no longer be 
in control of what decision is taken and may not even know or understand why a wrong decision has been taken, because 
the transparency is being lost. Currently, AI within the NHS is considered to be a tool supporting staff rather than acting 
as sole decision maker meaning medical professionals are always held accountable for decisions regardless of whether 
these decisions were influenced by AI technology or not. The fact that NHS professionals can be held accountable for 
decisions influenced by potentially inaccurate AI, which cannot even be proven in some situations due to lack of 
transparency, may deter them from embracing the AI movement.  
 
If AI is to take on a greater role in supporting clinicians in decision making then it would seem appropriate that the issue 
of transparency is addressed. The development of transparent machine learning techniques would not only benefit the 
current accountability dilemma in AI but also address the previously mentioned regulatory issues and therefore is an 
important area for research to focus on. Tackling transparency in artificial intelligence and specifically machine learning 
can be somewhat challenging however current research suggests that it could be possible. For example, MIT scientists 
have recently developed methods for developing transparent deep learning neural networks (18) and while developing 
its AI eye detection technology, DeepMind specifically tackled this issue by creating a solution that displays selected 
information regarding how the program arrived at its recommendation (2). Despite these promising examples, 
technological solutions to making machine learning transparent is still in its youth and would require developers with 
expertise in this new area which may not be an available resource. Another approach is to develop auditing systems that 
explain the inner workings of these algorithms. The realising Accountable Intelligent Systems (RAInS) project, 
currently being developed by the collaboration of the university of Aberdeen, Cambridge and Oxford aims to do just 
that by developing prototype solutions that generate “secure, tamper-proof records of intelligent systems’ characteristics 
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and behaviours” and can be provided to the necessary bodies in the case of an adverse event in order to ensure AI 
systems are transparent and accountable (19). 
 
Public trust 
 
Obtaining public trust and support in AI is crucial to its successful deployment within the NHS. Current reports, 
however, suggest that the NHS may currently be in a less than desirable position with one recent poll finding that only 
20% of respondents support the use of AI in healthcare with 48% opposing its use (20). Although there are numerous 
AI success stories in recent years, these have arguably been outshined by catastrophic AI failures, which have inevitably 
dented the publics already limited trust in the use of AI within daily life. For example, in March 2018 an AI powered 
Uber vehicle failed to detect a female pedestrian crossing the road ultimately resulting in the first pedestrian death from 
an autonomous car (21). These high-profile incidents in combination with the unfamiliarity and lack of understanding 
a significant portion of the public currently associate with AI presents as a significant problem for the NHS. Gaining 
public trust in the use of AI, however, is essential for its growth and measures must be carried out by relevant parties 
including the government to achieve this. As stated by Norman Lamb with regards to AI in healthcare, “trust is going 
to be of central importance – if we lose the trust of people then we won’t be able to realise the great opportunities ahead 
of us.” (22)  
 
If the NHS is to gain public trust in the use of AI within its daily practice, then empowering patients with appropriate 
information is crucial. To combat high profile AI failures, successful developments in AI use within the NHS should be 
communicated to the public. If people are aware of the benefit AI is regularly bringing to healthcare then failures may 
be seen as an anomaly rather than a common occurrence. Efforts also need to be made not only to ensure that patients 
are sufficiently educated on current technology but also reassured this technology is safe and developed according to 
the relevant technical and ethical standards. In the recent AI sector deal, the government established various 
organisations designed to oversee the safe and ethical development of AI such as the centre for data ethics and 
innovation, an AI council and a central office for AI (5). Additionally, the government has stated it will aim to introduce 
a trusted approval scheme for digitial and healthcare products, similar to the NHS health apps library which currently 
identifies trusted digital apps for use by the public and organisations (14). The existence of these schemes and 
institutions, in combination with relevant regulatory bodies, should hopefully provide an appropriate framework to 
reassure the public that development of AI is subject to sufficient monitoring, ethical considerations and appropriate 
regulation. 
 
Education  
 
Education of NHS staff is a hugely important factor in aiding the growth of AI within the NHS. Ultimately, even if 
trusts have access to the latest AI technology, this is of little use if staff are not equipped with the necessary skillsets in 
order to utilise this technology. Commonly, technological advances are introduced to businesses with insufficient 
support to staff in adapting to these new technologies which inevitably leads to failure. As stated by Matt Hancock, with 
regards to AI integration in the NHS “only 10% of the challenge is the tech, 90% is the culture” and this is particularly 
applicable to NHS staff where AI technology may appear at present to be an enigma (23). The Government has identified 
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the need for this and has currently commissioned a review (The Topol Review) into how NHS staff should best be trained 
in order to support use of new digital technologies. In the report, it states that all clinicians should be educated in the 
ethical standards and good practice of working with AI including the ability to interpretate clinical statistics and 
understand recommendations generated by AI systems (24). Specific details regarding how this will be addressed and 
deployed is not currently clear however will be important to address in the near future to best aid NHS staff.   
 
Within the interim report, the importance of relevant teaching within undergraduate education is also highlighted. 
Current research suggests that medicine is moving from an information age into an age of artificial intelligence and 
medical education reforms need to acknowledge and embrace this movement (25). Despite this need being recognised, 
medical school curriculums and graduate medical education programmes across the world are failing to address this and 
educate students appropriately on the use of AI and other relevant technology within medicine. Within Boston 
University Medical school, this requirement was recognised by one professor who responded by establishing an 
introductory course to machine learning for medical professionals. As part of the course, students are educated on real 
life ML applications in medicine and taught the necessary skillsets to analyse data using machine learning techniques 
(26). By adopting a similar approach within UK universities, not only would students be more confident and comfortable 
using AI technology at later stages of their career but also the burden of educating staff within the NHS could be lessened 
if this teaching has already been delivered at an earlier stage.  
 
Outlook on the future of AI within the NHS  
 
Ultimately, the use of artificial intelligence within the NHS has the potential to significantly improve patient care if 
appropriate measures are put in place to address current barriers the NHS is facing. The recent development of more 
accurate AI methods, specifically deep learning, has the potential to benefit a variety of areas including medical imaging 
analysis, administration and diagnostic support. If automation is sufficiently adopted, hundreds of hours of staff time 
per year could be freed, greatly impacting the current healthcare landscape and addressing financial and performance 
pressures on the NHS.  
 
To reap the eventual benefits of such sophisticated technology, there are several barriers which first need to be overcome. 
Notably, current known inadequacies associated with NHS data sets continue to pose problems to developers in 
implementing AI applications throughout the development process. The establishment of an improved framework would 
ensure accurate machine-readable data sets are easily accessible to approved developers and perhaps combat this issue. 
Additionally, a multitude of issues surrounding current deep learning capabilities come to light, with research into 
transparent methods of machine learning vital if AI is to become incorporated into daily healthcare practice. Addressing 
this could quell the aforementioned regulatory and accountability concerns by ensuring the logic behind algorithms is 
available and clear to the user. Expanding appropriate education to the public and medical professionals is also crucial 
to the successful integration of AI within healthcare as it is clear without such measures the value of this technology 
will be limited or even hindered. While the Topol Report indicates that education for NHS staff is a key priority for the 
near future, concrete plans on how education at an undergraduate level will be addressed are yet to be seen. It is against 
this backdrop we can conclude that although it may be some years before the NHS is fully able to utilise the undeniable 
potential of AI, such time allows for necessary advanced education and preparation for the inevitable AI movement.  
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Appendix A 
 
DeepMind and Moorfields Eye hospital  
 
The collaboration between DeepMind and Moorfields eye hospital began in 2016 with the aim of investigating whether 
Artificial intelligence could be used to aid clinicians in diagnosing and treating a range of eye conditions. The technology 
uses deep learning methods to analyse and classify OCT (optical coherence tomography) scans which can be difficult 
to interpret from human sight alone and currently require analysis from experts.  As stated by DeepMind, the time 
required to analyse these scans in addition to the vast number of scans produced each day can produce lengthy delays 
which could be significantly reduced with widespread use of this software. Additionally, the system can prioritise 
patients based on urgent need of care. The initial results of the project were recently published (1) demonstrating that 
the new technology can correctly identify categories of eye disease 94.5% of the time, the same accuracy if not better 
than leading consultant ophthalmologists at MoorFields Eye Hospital. Currently, the technology is set to be used within 
clinical trials with the ultimate goal of integration into daily clinical practice.  
 
(2)- https://deepmind.com/blog/moorfields-major-milestone/#image-31930 
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Appendix B 
 
Heartflow software uses deep learning technology to analyse data from CT scans in order to create a three-
dimensional model of coronary arteries analysing blood flow and blockages within the heart. Estimated by the 
National institute for health and care excellence (NICE) to save the NHS almost £9.1 million a year (3), Heartflow 
aims to reduce the time taken to diagnose and establish a treatment plan for coronary heart disease if used widely 
within the NHS. As part of the innovation and technology payment programme (ITP) which was established to aid 
appropriate technology in being adopted faster within the NHS, Heartflow (4) was selected to be fast-tracked into the 
NHS with the aim to distribute the software within 35 NHS hospital by 2019. 
 
 
 
 
 
 
 
 
 
 
 
(5) - 
https://www.heartflow.com/?gclid=EAIaIQobChMIo9W_uLPg3gIVGOR3Ch0lxwvSEAAYASAAEgIauvD_BwE 
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Appendix C 
 
Artificial Intelligence – Subdivisions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Machine learning  
 
 
 
 
 
 
 
 
 
 
Machine learning: 
Machine learning is a subset of artificial intelligence that allows programs to learn without being explicitly 
programmed. In machine learning, systems learn from datasets, identify patterns within these datasets and use this 
information to make predictions about data it has not been previously exposed to.  
 
Deep learning: 
Deep learning is a relatively new (see graph 1) subset of machine learning which uses algorithms that replicate the 
human brain (neural networks) in structure and function. In machine learning, the more data the algorithm can utilise, 
the greater the performance of the system. In older styles of machine learning, algorithms eventually reach a plateau in 
performance regardless of how much additional data is used to train the algorithm (see graph 2). Deep learning, 
however, can utilise greater quantities of data leading to higher levels of accuracy in algorithms that previously wasn’t 
achievable – this is one of the main reasons deep learning has revolutionised the AI field today.  
 
Despite the advantages with regards to increased performance, one of the major drawbacks of deep learning is the lack 
of transparency in the operation of the algorithm (known as a black box system). In deep learning, it is possible to 
view the input and output of algorithms but difficult, even for developers, to determine how the algorithm produced its 
output. This proves significantly problematic in disciplines such as healthcare where justification for decisions 
reached is crucial to ensure maximum safety for patients.  
 
 
 
 
 
Black box system 
Input Output 
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Appendix D: poster component of ME33A2 
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